Nature Publishing Group, publisher of Nature, and other science journals and reference works
nature.com about npg news@nature.com naturejobs natureevents help site index
Nature
my accounte-alertssubscriberegister
SEARCH JOURNAL   advanced search
Friday 23 March 2018
Journal Home
Table of Contents
AOP
Archive
Highlights
Feature of the Week
The Nature top ten
Insights
Tech Features
For Authors
Permissions
About Nature
Contact Nature
Advertising
  
 
Gateways
Asia gateway
German gateway
Japan gateway
 
 
  Vol 430 No 6996 (Insight) pp241-271

8 July 2004

  

Infection and immunity

URSULA WEISS
Senior Editor

Infectious diseases remain a serious medical burden in both developing and industrialized countries. The emergence of new diseases such as HIV/AIDS and severe acute respiratory syndrome (SARS), the resurgence of known diseases such as West Nile disease and multidrugresistant tuberculosis, and the threat of deliberately developed man-made infections are cause for concern. When vaccines or effective treatments are not available, we rely on the immune system to clear the host of infectious agents and disease. A better understanding of the tactics used by pathogens and of the immune system�s defensive armoury is needed to pave the way for improved strategies of prevention and therapy. The four articles in this Insight provide a snapshot of the issue, addressing in turn the nature and spread of emerging and re-emerging infectious diseases, the assault strategies used by major pathogens, the immediate innate immune response, and the antigen-specific acquired (or adaptive) immune response, which is the host�s second line of defence.

David Morens, Gregory Folkers and Anthony Fauci review new and old infectious diseases that pose challenges for public health in the twenty-first century. Scott Merrell and Stanley Falkow discuss the strategies that pathogens use to evade the host�s defences and secure their own survival. Bruce Beutler reviews the role of Toll-like receptors (TLRs) in early detection of and defence against pathogens in relation to clinical applications, and discusses how TLRs may contribute to autoimmunity and sterile inflammation. And Marianne Boes and Hidde Ploegh review successive stages of T-cell activation from a cellbiological perspective, discussing how functional data obtained in vitro may translate to an in vivo setting.

These articles provide an overview of the current status of each field,
and consider directions for future research. We are indebted to the
authors who contributed to this Insight, and we hope that you will find
the reviews informative and stimulating.

  Insight
  Infection and immunity 241
URSULA WEISS
doi:10.1038/430241a
Full text | PDF (195k)
  The challenge of emerging and re-emerging infectious diseases 242
DAVID M. MORENS, GREGORY K. FOLKERS & ANTHONY S. FAUCI
doi:10.1038/nature02759
Summary | Full text | PDF (2268k)
  Frontal and stealth attack strategies in microbial pathogenesis 250
D. SCOTT MERRELL AND STANLEY FALKOW
doi:10.1038/nature02760
Summary | Full text | PDF (581k)
  Inferences, questions and possibilities in Toll-like receptor signalling 257
BRUCE BEUTLER
doi:10.1038/nature02761
Summary | Full text | PDF (301k)
  Translating cell biology in vitro to immunity in vivo 264
MARIANNE BOES AND HIDDE L. PLOEGH
doi:10.1038/nature02762
Summary | Full text | PDF (1008k)
Back to main issue
Home | Table of Contents | Advance Online Publication | Archive | Highlights | Feature of the Week
The Nature top ten | Insights | Tech Features | Authors | Permissions
About Nature | Advertising | Contact Nature
© 2004 Nature Publishing Group
Privacy Policy